Cargando…

Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma

The tripartite motif containing 23 (TRIM23) gene is a member of the tripartite motif (TRIM) family that participates in many pathophysiological processes. However, the role of TRIM23 in lung adenocarcinoma (LUAD) remains unclear. In the present study, TRIM23 was first screened by next‐generation seq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Youwei, Du, He, Li, Yang, Yuan, Yuan, Chen, Bi, Sun, Sanyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004530/ https://www.ncbi.nlm.nih.gov/pubmed/31677335 http://dx.doi.org/10.1111/cas.14226

Ejemplares similares

CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA‐146a and microRNA‐26a
por: Du, He, et al.
Publicado: (2020)

Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma
por: Du, He, et al.
Publicado: (2020)

NOTCH3 Overexpression and Posttranscriptional Regulation by miR-150 Were Associated With EGFR–TKI Resistance in Lung Adenocarcinoma
por: Zhang, Youwei, et al.
Publicado: (2019)

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA
por: Zhang, Shuai, et al.
Publicado: (2022)

lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2020)

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance
por: Ma, Qingshan, et al.
Publicado: (2012)

Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
por: Gao, Zhao-jia, et al.
Publicado: (2018)

Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma
por: Hu, Lijuan, et al.
Publicado: (2017)

Identification of TRIM56 as a Potential Biomarker for Lung Adenocarcinoma
por: Lu, Kun, et al.
Publicado: (2021)

Nasal Sculpting: Calculated and Predictable Tip Elevation With Cephalic Trim
por: Redstone, Jeremiah S., et al.
Publicado: (2015)

Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin
por: Wang, Yuanyi, et al.
Publicado: (2023)

Low expression of PRKCDBP promoted cisplatin resistance in lung adenocarcinoma by DNMT1 and TNF-α
por: Fu, Jiali, et al.
Publicado: (2020)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020)

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2020)

The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
por: Liu, Jing, et al.
Publicado: (2015)

TRIM29 as a Novel Biomarker in Pancreatic Adenocarcinoma
por: Sun, Hongli, et al.
Publicado: (2014)

HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway
por: Liang, Jiaqi, et al.
Publicado: (2023)

WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma
por: Gong, Lian, et al.
Publicado: (2020)

Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma
por: Hiyama, Noriko, et al.
Publicado: (2018)

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma
por: Hastings, Jordan F, et al.
Publicado: (2020)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Publicado: (2023)

TRIM37 targets AKT in the growth of lung cancer cells
por: Dong, Shumin, et al.
Publicado: (2018)

Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2016)

Serum Protein Pattern Could Predict the Therapeutic Effect of First-Line Pemetrexed/Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
por: Shen, Hong, et al.
Publicado: (2015)

Trim Magnet Polarities, Dispersion, and Response Data in Sector 23
por: Butterworth, A, et al.
Publicado: (2008)

Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death
por: Liu, Wen-Jun, et al.
Publicado: (2022)

Elevation of TRIM44 potentiates propagation of gastric cancer stem cells
por: Zhu, Hai, et al.
Publicado: (2021)

TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma
por: Liu, Jie, et al.
Publicado: (2020)

Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer
por: Gao, Yanan, et al.
Publicado: (2021)

Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance
por: Su, Yinjie, et al.
Publicado: (2019)

HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients
por: Zhan, Jun, et al.
Publicado: (2019)

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
por: Fu, Jiali, et al.
Publicado: (2021)

Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells
por: He, Jinxi, et al.
Publicado: (2017)

Grouper TRIM23 exerts antiviral activity against iridovirus and nodavirus
por: Zhi, Linyong, et al.
Publicado: (2022)

Increased ABCC2 expression predicts cisplatin resistance in non‐small cell lung cancer
por: Chen, Yun, et al.
Publicado: (2020)

Opposing roles of E3 ligases TRIM23 and TRIM21 in regulation of ion channel ANO1 protein levels
por: Cao, Xu, et al.
Publicado: (2021)

TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer
por: Han, Yudong, et al.
Publicado: (2020)

N6-methyladenosine of TRIM27 enhances the stem cell-type phenotype of cisplatin-resistant colorectal cancer cells
por: Zheng, Jun-qiong, et al.
Publicado: (2023)

Elevated expression of JAM‐A promotes neoplastic properties of lung adenocarcinoma
por: Magara, Kazufumi, et al.
Publicado: (2017)

Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
por: Gong, Lian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uso0vq3belhhhnflja7na0614i